Ulthera
Ulthera develops and sells FDA-cleared Ultherapy PRIME, a microfocused ultrasound platform with real-time visualization for non-invasive skin lifting, sold via direct enterprise sales to dermatologists, plastic surgeons, and MedSpas across 80+ countries as a Merz Aesthetics subsidiary.
- Company typePrivate
- Founded2004
- HeadquartersMesa, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ulthera does
Ulthera, Inc. is a U.S.-incorporated medical technology company that develops and commercializes non-invasive microfocused ultrasound devices with real-time visualization for aesthetic skin lifting. Founded in 2004 and headquartered as a wholly-owned subsidiary of Merz North America, Inc. (within the Merz Pharma GmbH & Co. KGaA group), the company's flagship platforms — Ultherapy and the next-generation Ultherapy PRIME (FDA-cleared 2024) — target the same deep tissue planes (SMAS) as a surgical facelift using patented DeepSEE transducers that simultaneously visualize and treat at 1.5 mm, 3 mm, and 4.5 mm depths, producing thermal coagulation points at 60–70°C to stimulate neocollagenesis (clinical data shows a 42% increase in collagen synthesis). Successive FDA clearances have expanded indications from brow lift (2009) to neck and chin (2012), décolleté (2014), and arms and abdomen (2025).
Ulthera firmographics
Firmographics- Name
- Ulthera
- Legal name
- Ulthera, Inc.
- Website
- https://ultherapy.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Ulthera develops and sells FDA-cleared Ultherapy PRIME, a microfocused ultrasound platform with real-time visualization for non-invasive skin lifting, sold via direct enterprise sales to dermatologists, plastic surgeons, and MedSpas across 80+ countries as a Merz Aesthetics subsidiary.
- Ownership category
- akta.pro rank
Ulthera industry classification
Industry- Product category
- Energy-based Aesthetic Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Facial Plastic & Reconstructive Surgery (ENT) (HLAKAMAG)
- akta.pro secondary industries
- Wound Care & Ulcer Management (HLAKACAN), Spa Body Treatments & Massage (Oils, Scrubs, Wraps) (CRABALAG)
Keywords
Where Ulthera is headquartered
LocationHeadquarters
- HQ city
- Mesa
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ulthera business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations, Infrastructure
Revenue model
- Capital Equipment Sales: Ultherapy PRIME device sold to licensed physicians, dermatologists, plastic surgeons, and MedSpas. Practices must purchase the capital equipment to offer treatments. The Merz Advantage Loyalty Program rewards providers for device and consumable purchases.
- Transducer Consumables: Multi-patient-use transducers are consumable components that must be repurchased. Providers earn points through the Merz Advantage Loyalty Program for consumable purchases including transducers.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels8 records
Ulthera product offering
Product offeringCore offering
Ulthera designs, manufactures, and sells FDA-cleared non-invasive microfocused ultrasound systems (Ultherapy and Ultherapy PRIME) used by licensed physicians to lift and tighten skin on the brow, neck, under the chin, décolleté, arms, and abdomen. The company sells capital equipment and recurring replacement DeepSEE transducers, supported by clinical training, practice marketing, and a provider loyalty program.
Product overview
Ulthera offers a portfolio of non-invasive aesthetic ultrasound devices centered on two core products: Ultherapy PRIME (the advanced platform) and Ultherapy (the original Gold Standard device). Both use microfocused ultrasound with real-time DeepSEE visualization technology to stimulate collagen production and deliver personalized skin lifting treatments. The product line includes patented DeepSEE transducers for multi-depth treatment, the Selfie Simulator for patient visualization (powered by third-party partner Crisalix SA), and provider support tools including My Merz Portal and the Merz Advantage Loyalty Program. The system is FDA-cleared to treat the brow, neck, chin, and décolleté, with recent 2025 clearance expanding to arms and abdomen.
Differentiator
Problem solved
Functional benefit
Brands
- Ultherapy PRIME: The latest advanced platform for non-invasive microfocused ultrasound skin lifting treatment with real-time visualization, featuring 20% faster treatment times and enhanced ergonomic design.
- DeepSEE
Products and services
- Ultherapy PRIME Next-generation FDA-cleared non-invasive microfocused ultrasound device with real-time visualization for personalized skin lifting on the brow, neck, under chin, décolleté, arms, and abdomen. Sold to licensed physicians and MedSpas.
- Ultherapy The original FDA-cleared Gold Standard non-invasive microfocused ultrasound device with real-time visualization for lifting skin on the brow, neck, under the chin, and décolleté by stimulating the body's own collagen production. Sold to licensed physicians.
- DeepSEE Transducers Patented multi-patient-use transducers for the Ultherapy system providing simultaneous visualization and treatment at three separate depths (1.5mm superficial dermis, 3mm deep dermis, 4.5mm SMAS/platysma), with collimated ultrasound visualization up to 8mm. Sold as recurring consumable components to providers.
Quantifiable outcome
- 95% patient satisfaction at year one
- +5 more outcomes
Companies that use Ulthera
Customer profileNamed customers6 records
Segments2 records
Ideal customer profiles2 records
Ulthera technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Ulthera partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Merz AestheticscoreMerz Aesthetics acquired Ulthera in 2015 and serves as the parent company behind Ultherapy PRIME. Merz provides corporate brand awareness marketing, practice support, sales tools, clinical training, and ongoing platform development. The partnership represents a significant aesthetic company integrating an established non-invasive lifting technology into its portfolio.
Scale indicators9 records
Recent moves6 records
Expansion highlights5 records
Ulthera competitors and assessment
Company assessmentDirect peers
- Sciton: Sciton's SkinTyte (BBL) and Joule platform compete in non-invasive skin tightening and rejuvenation, targeting the same physician practice and MedSpa customer base as Ulthera.
- Cynosure: Cynosure (Hologic) markets energy-based aesthetic devices including TempSure and Potenza that overlap with Ultherapy in skin tightening and rejuvenation, distributed to the same aesthetics provider base.
- InMode: InMode offers a portfolio of energy-based aesthetic platforms (Morpheus8 RF-microneedling, Forma, BodyTite) that compete with Ultherapy in skin tightening and rejuvenation, sold through the same physician and MedSpa channels.
- Solta Medical: Solta's Thermage FLX system competes with Ultherapy in non-invasive skin tightening and lifting using radiofrequency energy, sold into the same aesthetics practice channels with a similar capital equipment + consumable (tip) model.
- Sofwave Medical: Sofwave competes directly with Ultherapy in non-invasive ultrasound skin lifting through its Synchronous Ultrasound Parallel Beam SUPERB technology, marketed to the same dermatology, plastic surgery, and MedSpa customer base.
- BTL Industries: BTL's Exilis and Emface platforms compete with Ultherapy in non-invasive skin tightening and facial muscle toning, sold through the same aesthetics practice channels with recurring consumable revenue.
- Cutera: Cutera's truSculpt and Secret RF systems compete with Ultherapy in body contouring and skin rejuvenation, sold to dermatologists, plastic surgeons, and MedSpas with similar capital + consumable economics.
- Alma Lasers: Alma's Accent, Soprano, and other platforms compete in non-invasive skin tightening and rejuvenation, sold into dermatology and MedSpa channels with comparable capital equipment + consumable business models.
Broad incumbents
- AbbVie (Allergan Aesthetics): AbbVie's Allergan Aesthetics division (CoolSculpting, SkinMedica) competes as a broad incumbent in the medical aesthetics market, sharing Ulthera's dermatology and plastic surgeon customer base and overlapping in skin rejuvenation.
- Galderma: Galderma is a broad incumbent in aesthetic dermatology (injectables, skincare, and growing energy-based device presence), competing for the same physician mindshare and MedSpa budgets as Ulthera.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Ulthera social profiles
Digital presenceUlthera financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ulthera leadership team
Management profileNumber of profiles
Profiles2 records
Ulthera funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ulthera M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ulthera
What does Ulthera do?
Ulthera designs, manufactures, and sells FDA-cleared non-invasive microfocused ultrasound systems (Ultherapy and Ultherapy PRIME) used by licensed physicians to lift and tighten skin on the brow, neck, under the chin, décolleté, arms, and abdomen. The company sells capital equipment and recurring replacement DeepSEE transducers, supported by clinical training, practice marketing, and a provider loyalty program.
Is Ulthera a public or private company?
Ulthera is a private company. It is classified as corporate owned and is currently operating.
When was Ulthera founded?
Ulthera was founded in 2004. It employs 101 to 250 people.
Where is Ulthera based?
Ulthera is headquartered in Mesa, United States, in the North America region.
How does Ulthera make money?
Two revenue lines are on record. Capital Equipment Sales are the primary driver. The others are transducer Consumables.
Who are Ulthera's main competitors?
Direct peers on record are Sciton, Cynosure, InMode, Solta Medical, Sofwave Medical, BTL Industries, Cutera and Alma Lasers. Broad incumbents are AbbVie (Allergan Aesthetics) and Galderma.
Does Ulthera have an API?
No public API is recorded for Ulthera.
What industry is Ulthera in?
Ulthera's product category is Energy-based Aesthetic Medical Devices. Its primary akta.pro industry code is HLAKAMAG, Facial Plastic & Reconstructive Surgery (ENT), with a secondary code of HLAKACAN, Wound Care & Ulcer Management. Its NAICS code is 334510 and its SIC code is 3841.